Boston College researchers develop new type of 'cross coupling' chemical reaction

By employing a third reactant, researchers at Boston College have developed a new type of 'cross coupling' chemical reaction, building on a Nobel Prize-winning technique that is one of the most sophisticated tools available to research chemists, the team reports in the journal Science.

Transition metal catalyzed cross-coupling reactions were the subject of the 2010 Nobel Prize in chemistry. A key component of that novel approach -- known as Suzuki-Miyaura coupling -- connects two types of reactants, including one electron donor and one electron acceptor.

Boston College Professor of Chemistry James P. Morken and his team report using transition metals to develop an alternative cross-coupling process that merges two electron donors while they react with the electron acceptor. The resulting 'conjunctive' reaction takes place efficiently and offers a high degree of selectivity, the team reports.

"Our first significant step was determining that transition metals could facilitate the merger of two organic reactants in a manner commonly observed for other non-metallic chemical reagents," said Morken, the Louise and James Vanderslice and Family Professor of Chemistry at BC. "Once the team made this connection, then we narrowed our focus to consider ways in which catalysis might be achieved."

In a field as widely studied as transition metal cross-coupling, Morken said the researchers were surprised to uncover a new variation on the ground-breaking catalytic method. The team's early research shows that the new type of reaction can be efficient and selective, two characteristics prized by the researchers who use these types of catalysts, Morken said.

The team's focus is now on finding abundant and cost-effective metal compounds to enable the three-reactant cross-coupling, said Morken, whose research team included graduate students Liang Zhang, Gabriel J. Lovinger, Emma K. Edelstein, Adam A. Szymaniak, and Matteo P. Chierchia.

"Our team is addressing the limitations found in the early stage development and I think in the long-term that this mode of catalysis will have an impact on the way organic compounds are manufactured, most likely those used in the pharmaceutical industry," said Morken. "If the underlying reactivity can be used in other catalytic chemical processes, then that should open up a broad new collection of chemical reactions that will be of use in chemical manufacture."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New AI tool maps millions of CD8+ T cells to advance disease research